About C-type lectin domain family 14 member A
C-type lectin domain family 14 member A (CLEC14A) is a protein
from Homo sapiens identified by UniProt accession
Q86T13, 490 residues long.
MolForge cross-references it against 0 known binders and
46 disease associations.
Target properties
| Protein name | C-type lectin domain family 14 member A |
| UniProt accession | Q86T13 |
| Gene | CLEC14A |
| Organism | Homo sapiens |
| Length | 490 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (46)
Diseases linked to this target (Open Targets).
- type 2 diabetes mellitus · score 0.38
- neurodegenerative disease · score 0.31
- Drugs used in diabetes use measurement · score 0.31
- diabetes mellitus · score 0.31
- HbA1c measurement · score 0.27
- glucose tolerance test · score 0.25
- endocrine system disease · score 0.24
- 5-HIAA measurement · score 0.13
- MHPG measurement · score 0.13
- anxiety · score 0.13
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q86T13-F1 | alphafold | PREDICTED | 68.52 | — |
Amino-acid sequence (490 residues)
MRPAFALCLL WQALWPGPGG GEHPTADRAG CSASGACYSL HHATMKRQAA EEACILRGGA LSTVRAGAEL RAVLALLRAG PGPGGGSKDL LFWVALERRR SHCTLENEPL RGFSWLSSDP GGLESDTLQW VEEPQRSCTA RRCAVLQATG GVEPAGWKEM RCHLRANGYL CKYQFEVLCP APRPGAASNL SYRAPFQLHS AALDFSPPGT EVSALCRGQL PISVTCIADE IGARWDKLSG DVLCPCPGRY LRAGKCAELP NCLDDLGGFA CECATGFELG KDGRSCVTSG EGQPTLGGTG VPTRRPPATA TSPVPQRTWP IRVDEKLGET PLVPEQDNSV TSIPEIPRWG SQSTMSTLQM SLQAESKATI TPSGSVISKF NSTTSSATPQ AFDSSSAVVF IFVSTAVVVL VILTMTVLGL VKLCFHESPS SQPRKESMGP PGLESDPEPA ALGSSSAHCT NNGVKVGDCD LRDRAEGALL AESPLGSSDA
Explore C-type lectin domain family 14 member A with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets